Effects of apelin on the cardiovascular system.

Abstract:

:Apelin is an endogenous peptide acting on the APJ receptor. It consists of several isoforms characterized by different numbers of amino acids. The number of amino acids in the active isoforms range from 36 to 12. Apelin-13 and, to a lesser extent, apelin-36 are considered the most active isoforms with the greatest activity on the cardiovascular homeostasis. The effects normally exerted by the basal level of endogenous apelin can be enhanced not only by its up-regulation, but may also by its exogenous administration. The present review considers the effects of apelin on various aspects of the cardiovascular function, such as cardiac development, vasomotor tone, angiogenesis, myocardial inotropy in healthy and failing hearts as well as the prevention of ischemia-reperfusion injury, cardiac fibrosis and remodeling. Also the biphasic changes in apelin level during the evolution of heart failure are considered. Although the positive inotropic effect exerted by apelin in normal and failing hearts would suggest the use of this peptide in the treatment of heart failure, the limited duration and extent of its effect do not support this possibility, unless a long-lasting (6 h) infusion is performed to overcome the limit of its short life. However, although the data on the characteristics of the inotropic activity do not provide a strong support for the treatment of active heart failure, apelin may be used in the prevention of heart failure because of its activity in limiting the consequences of myocardial ischemia such as infarct size and cardiac remodeling.

journal_name

Heart Fail Rev

journal_title

Heart failure reviews

authors

Folino A,Montarolo PG,Samaja M,Rastaldo R

doi

10.1007/s10741-015-9475-x

subject

Has Abstract

pub_date

2015-07-01 00:00:00

pages

505-18

issue

4

eissn

1382-4147

issn

1573-7322

journal_volume

20

pub_type

杂志文章,评审
  • Chronic heart failure: a disease of the brain.

    abstract::The underlying mechanism for clinical and biochemical manifestations of chronic heart failure (HF) may be due in part to neurohumoral adaptations, such as activation of the renin-angiotensin-aldosterone and sympathetic nervous systems in the periphery and the brain. Internet search and discussion with colleagues are t...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9747-3

    authors: Singh RB,Hristova K,Fedacko J,El-Kilany G,Cornelissen G

    更新日期:2019-03-01 00:00:00

  • Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.

    abstract::The development of a diabetic cardiomyopathy is a multifactorial process, and evidence is accumulating that defects in intracellular free calcium concentration [Ca2+]i or its homeostasis are related to impaired mechanical performance of the diabetic heart leading to a reduction in contractile dysfunction. Defects in r...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9663-y

    authors: Singh RM,Waqar T,Howarth FC,Adeghate E,Bidasee K,Singh J

    更新日期:2018-01-01 00:00:00

  • Angiotensin II and nitric oxide interaction.

    abstract::Nitric oxide degradation linked to endothelial dysfunction plays a central role in cardiovascular diseases. Superoxide producing enzymes such as NADPH oxidase and xanthine oxidase are responsible for NO degradation as they generate a variety of reactive oxygen species (ROS). Moreover, superoxide is rapidly degraded by...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1020714518246

    authors: de Gasparo M

    更新日期:2002-10-01 00:00:00

  • Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?

    abstract::Acute heart failure syndromes (AHFS) are associated with the rapid onset of heart failure (HF) signs and symptoms. Hospitalizations for AHFS continue to rise and are associated with significant mortality and morbidity. Several pharmacological agents are currently approved for the treatment of AHFS, but their use is as...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-009-9136-z

    authors: Khan H,Metra M,Blair JE,Vogel M,Harinstein ME,Filippatos GS,Sabbah HN,Porchet H,Valentini G,Gheorghiade M

    更新日期:2009-12-01 00:00:00

  • Pulmonary hypertension associated with lung diseases and hypoxemia.

    abstract::Pulmonary hypertension that develops in the setting of underlying lung diseases such as COPD or idiopathic pulmonary fibrosis (IPF) is associated with decreased functional status, worsening hypoxemia and quality of life, and increased mortality. This complication of lung disease is complex in its origin and carries a ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-016-9551-x

    authors: Cuttica MJ

    更新日期:2016-05-01 00:00:00

  • The management of conditioned nutritional requirements in heart failure.

    abstract::Patients suffering from congestive heart failure exhibit impaired myocardial energy production, myocyte calcium overload and increased oxidative stress. Nutritional factors known to be important for myocardial energy production, calcium homeostasis and the reduction of oxidative stress, such as thiamine, riboflavin, p...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-006-9195-3

    authors: Allard ML,Jeejeebhoy KN,Sole MJ

    更新日期:2006-03-01 00:00:00

  • (1)H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism.

    abstract::Magnetic resonance spectroscopy (MRS) is the only non-invasive, non-radiation-based technique for investigating the metabolism of living tissue. MRS of protons (1H-MRS), which provides the highest sensitivity of all MR-visible nuclei, is a method capable of detecting and quantifying specific cardiac biomolecules, such...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9341-z

    authors: Faller KM,Lygate CA,Neubauer S,Schneider JE

    更新日期:2013-09-01 00:00:00

  • Non-ischemic dilated cardiomyopathy and cardiac fibrosis.

    abstract::Cardiac fibrosis is associated with non-ischemic dilated cardiomyopathy, increasing its morbidity and mortality. Cardiac fibroblast is the keystone of fibrogenesis, being activated by numerous cellular and humoral factors. Macrophages, CD4+ and CD8+ T cells, mast cells, and endothelial cells stimulate fibrogenesis dir...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09940-0

    authors: Cojan-Minzat BO,Zlibut A,Agoston-Coldea L

    更新日期:2020-03-13 00:00:00

  • Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.

    abstract::Despite remarkable progress in the therapeutic approach of patients with chronic heart failure (CHF), exercise intolerance remains one of the hallmarks of the disease. During the past two decades, evidence has accumulated to underscore the key role of both endothelial dysfunction and skeletal muscle wasting in the pro...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9324-0

    authors: Conraads VM,Van Craenenbroeck EM,De Maeyer C,Van Berendoncks AM,Beckers PJ,Vrints CJ

    更新日期:2013-01-01 00:00:00

  • Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.

    abstract::There are multiple intrinsic mechanisms for diastolic dysfunction ranging from molecular to structural derangements in ventricular myocardium. The molecular mechanisms regulating the progression from normal diastolic function to severe dysfunction still remain poorly understood. Recent studies suggest a potentially im...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-016-9569-0

    authors: Mikhailov AT,Torrado M

    更新日期:2016-11-01 00:00:00

  • Preconditioning in humans.

    abstract::Brief ischemia to the myocardium initiates a cascade of biochemical events in cardiac myocytes that protects the heart muscle during subsequent ischemic insults. This phenomenon is called ischemic preconditioning. If an acute myocardial infarction is preceded by preinfarction angina, it results in smaller infarction s...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-007-9037-y

    authors: Rezkalla SH,Kloner RA

    更新日期:2007-12-01 00:00:00

  • A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling.

    abstract::It is well established that cardiac remodeling plays a pivotal role in the development of heart failure, a leading cause of death worldwide. Meanwhile, sympathetic hyperactivity is an important factor in inducing cardiac remodeling. Therefore, an in-depth understanding of beta-adrenoceptor signaling pathways would hel...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-013-9417-4

    authors: Yang J,Liu Y,Fan X,Li Z,Cheng Y

    更新日期:2014-11-01 00:00:00

  • Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.

    abstract::Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide, with co-morbidities contributing to the overall severity and mortality of the disease. The incidence and prevalence of cardiovascular disease among COPD patients are high. Both disorders often co-exist, mainly due to smoking, but they al...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9646-z

    authors: Petta V,Perlikos F,Loukides S,Bakakos P,Chalkias A,Iacovidou N,Xanthos T,Tsekoura D,Hillas G

    更新日期:2017-11-01 00:00:00

  • New strategies for improving stem cell therapy in ischemic heart disease.

    abstract::Stem cell therapy is a promising approach to the treatment of ischemic heart disease via replenishing cell loss after myocardial infarction. Both preclinical studies and clinical trials have indicated that cardiac function improved consistently, but very modestly after cell-based therapy. This mainly attributed to low...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-016-9576-1

    authors: Huang P,Tian X,Li Q,Yang Y

    更新日期:2016-11-01 00:00:00

  • Biomarkers of inflammation in heart failure.

    abstract::Heart failure (HF) is characterized by the elaboration of a portfolio of pro-inflammatory cytokines and inflammatory mediators that are considered to contribute to disease progression by virtue of the deleterious effects that these molecules exert on the heart and circulation. Recent studies have suggested that these ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-009-9140-3

    authors: Bozkurt B,Mann DL,Deswal A

    更新日期:2010-07-01 00:00:00

  • Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

    abstract::Although several risk factors including hypertension, cardiac hypertrophy, coronary artery disease, and diabetes are known to result in heart failure, elderly subjects are more susceptible to myocardial infarction and more likely to develop heart failure. This article is intended to discuss that cardiac dysfunction in...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-011-9278-7

    authors: Dhalla NS,Rangi S,Babick AP,Zieroth S,Elimban V

    更新日期:2012-09-01 00:00:00

  • Diastolic heart failure: a confusing concept.

    abstract::Descriptions of the pathophysiology of heart failure have gone through a substantial evolution in the last 50 years. It is now recognised that heart failure can occur in the presence and also in the absence of a reduction in left ventricular function. In the former situation, this classically has been described to lea...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9344-9

    authors: Dorhout Mees EJ

    更新日期:2013-07-01 00:00:00

  • Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.

    abstract::The prevalence of heart failure (HF) is increasing. A distinction is made between diastolic HF (preserved left ventricular ejection fraction (LVEF)) and systolic HF (reduced LVEF). Advanced glycation end-products (AGEs) are crystallized proteins that accumulate during ageing, but are particularly increased in patients...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9225-z

    authors: Willemsen S,Hartog JW,Heiner-Fokkema MR,van Veldhuisen DJ,Voors AA

    更新日期:2012-03-01 00:00:00

  • Maintenance immunosuppression in heart transplantation: insights from network meta-analysis of various immunosuppression regimens.

    abstract::Previous studies have reported superiority of mechanistic target-of-rapamycin (mTOR) antagonists (mTA) over calcineurin inhibitors (CNI) as part of maintenance immunosuppression (IS) in mitigating cardiac allograft vasculopathy (CAV) after heart transplantation (HT). MEDLINE and EMBASE were searched through October 20...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09967-3

    authors: Ueyama H,Kuno T,Takagi H,Alvarez P,Asleh R,Briasoulis A

    更新日期:2020-05-18 00:00:00

  • Structural and functional abnormalities in iron-depleted heart.

    abstract::Iron deficiency (ID) is a common and ominous comorbidity in heart failure (HF) and predicts worse outcomes, independently of the presence of anaemia. Accumulated data from animal models of systemic ID suggest that ID is associated with several functional and structural abnormalities of the heart. However, the exact ro...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9738-4

    authors: Kobak KA,Radwańska M,Dzięgała M,Kasztura M,Josiak K,Banasiak W,Ponikowski P,Jankowska EA

    更新日期:2019-03-01 00:00:00

  • Nutrition intervention in heart failure: should consumption of the DASH eating pattern be recommended to improve outcomes?

    abstract::Heart failure (HF) is a chronic, systemic disorder that presents a serious and growing public health problem due to its high prevalence, mortality, and cost of care. Due to the aging of the population and medical advances that prolong the life of HF patients, more effective, widespread strategies for improved HF manag...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09781-6

    authors: Abu-Sawwa R,Dunbar SB,Quyyumi AA,Sattler ELP

    更新日期:2019-07-01 00:00:00

  • Aerobic exercise effect on prognostic markers for systolic heart failure patients: a systematic review and meta-analysis.

    abstract::From previous systematic reviews and meta-analyses, there is consensus about the positive effect of exercise training on exercise capacity for systolic heart failure (HF); however, the effect on actual prognostic markers such as NTproBNP and minute ventilation/carbon dioxide production (VE/VCO2) slope has not been eva...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s10741-013-9407-6

    authors: Cipriano G Jr,Cipriano VT,da Silva VZ,Cipriano GF,Chiappa GR,de Lima AC,Cahalin LP,Arena R

    更新日期:2014-09-01 00:00:00

  • Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings.

    abstract::It is over 4 years since the Prospective Comparison of angiotensin receptor/neprilysin inhibitor (ARNI) with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) trial was published in New England Journal of Medicine. The PARADIGM-HF trial was the one that contributed to the offici...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09879-x

    authors: Książczyk M,Lelonek M

    更新日期:2020-05-01 00:00:00

  • How does the heart (not) die? The role of autophagy in cardiomyocyte homeostasis and cell death.

    abstract::Autophagy plays a critical and seemingly dual-purposed role in cardiomyocytes, being implicated as a mechanism of both cellular survival, for example, during ischemia/reperfusion injury and a mechanism of cell death at stages in which progressive myocyte alterations are beyond repair. This review aims to highlight the...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-009-9137-y

    authors: Dhesi P,Tehrani F,Fuess J,Schwarz ER

    更新日期:2010-01-01 00:00:00

  • Immune cell diversity contributes to the pathogenesis of myocarditis.

    abstract::Myocarditis (MCD) is a type of inflammatory disease in which inflammatory cells infiltrate the myocardium, leading to cardiac dysfunction, myocardial necrosis, and fibrosis. Although it has been reported that MCD is mediated by T cells, the immune system is complex and includes many types of immune cells that interact...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09799-w

    authors: Hua X,Song J

    更新日期:2019-11-01 00:00:00

  • B-type natriuretic peptide: physiologic role and assay characteristics.

    abstract::The discovery of cardiac natriuretic peptides two decades ago has lead to considerable research to investigate their biochemical and physiological properties. Clearly the heart is not just a pump but is also an endocrine organ that together with the kidneys control volume overload. The natriuretic peptides are a group...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1026182912461

    authors: Azzazy HM,Christenson RH

    更新日期:2003-10-01 00:00:00

  • RV diastolic dysfunction: time to re-evaluate its importance in heart failure.

    abstract::Right ventricular (RV) diastolic dysfunction was first reported as an indicator for the assessment of ventricular dysfunction in heart failure a little over two decades ago. However, the underlying mechanisms and precise role of RV diastolic dysfunction in heart failure remain poorly described. Complexities in the str...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-015-9472-0

    authors: Axell RG,Hoole SP,Hampton-Till J,White PA

    更新日期:2015-05-01 00:00:00

  • How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

    abstract::Many factors contribute to the pathophysiology and progression of heart failure (HF), offering the potential for many synergistic therapeutic approaches to its management. For patients, who have systolic HF, prolonged QRS and receiving guideline-indicated pharmacological therapy, cardiac resynchronization therapy (CRT...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9351-x

    authors: Buga L

    更新日期:2012-11-01 00:00:00

  • Prevention of heart failure in the elderly: when, where and how to begin?

    abstract::Significant growth in the elderly population (age ≥ 65 years) with heart failure (HF) has taken place in developed countries and is occurring in most developing countries. Projections from population studies in the United States, Europe and other developed countries suggest that this trend will very likely continue an...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9299-x

    authors: Jugdutt BI

    更新日期:2012-09-01 00:00:00

  • Emerging concepts in arrhythmogenic dilated cardiomyopathy.

    abstract::Dilated cardiomyopathy (DCM) represents one of the primary cardiomyopathies and may lead to heart failure and sudden death. Until recently, ventricular arrhythmias were considered to be a direct consequence of the systolic dysfunction of the left ventricle (LV) and guidelines for implantable cardioverter defibrillator...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09933-z

    authors: Zegkos T,Panagiotidis T,Parcharidou D,Efthimiadis G

    更新日期:2020-02-13 00:00:00